nodes	percent_of_prediction	percent_of_DWPC	metapath
Progesterone—Hydrocortisone—psoriasis	0.18	0.543	CrCtD
Progesterone—Prednisolone—psoriasis	0.151	0.457	CrCtD
Progesterone—NR3C1—Clobetasol propionate—psoriasis	0.019	0.0627	CbGbCtD
Progesterone—NR3C2—Betamethasone—psoriasis	0.0149	0.0492	CbGbCtD
Progesterone—NR3C2—Prednisolone—psoriasis	0.0147	0.0485	CbGbCtD
Progesterone—NR3C1—Fluocinonide—psoriasis	0.0144	0.0475	CbGbCtD
Progesterone—NR3C1—Beclomethasone—psoriasis	0.0144	0.0475	CbGbCtD
Progesterone—NR3C1—Fluocinolone Acetonide—psoriasis	0.0144	0.0475	CbGbCtD
Progesterone—SLC10A1—Cyclosporine—psoriasis	0.0123	0.0405	CbGbCtD
Progesterone—CYP1A1—Clobetasol propionate—psoriasis	0.0113	0.0374	CbGbCtD
Progesterone—PGR—Betamethasone—psoriasis	0.00964	0.0318	CbGbCtD
Progesterone—Fluoxymesterone—Clobetasol propionate—psoriasis	0.00961	0.0356	CrCrCtD
Progesterone—Fludrocortisone—Clobetasol propionate—psoriasis	0.00936	0.0347	CrCrCtD
Progesterone—Hydrocortamate—Beclomethasone—psoriasis	0.00891	0.033	CrCrCtD
Progesterone—NR3C2—Dexamethasone—psoriasis	0.00868	0.0286	CbGbCtD
Progesterone—SHBG—Hydrocortisone—psoriasis	0.00866	0.0285	CbGbCtD
Progesterone—CYP17A1—Dexamethasone—psoriasis	0.0081	0.0267	CbGbCtD
Progesterone—Prednisolone—Clobetasol propionate—psoriasis	0.00796	0.0295	CrCrCtD
Progesterone—Eplerenone—Hydrocortisone—psoriasis	0.00786	0.0292	CrCrCtD
Progesterone—Fludrocortisone—Fluocinolone Acetonide—psoriasis	0.00729	0.027	CrCrCtD
Progesterone—CYP2A6—Methoxsalen—psoriasis	0.00697	0.023	CbGbCtD
Progesterone—Formestane—Hydrocortisone—psoriasis	0.00658	0.0244	CrCrCtD
Progesterone—Prednisolone—Beclomethasone—psoriasis	0.00637	0.0236	CrCrCtD
Progesterone—Drospirenone—Hydrocortisone—psoriasis	0.00625	0.0232	CrCrCtD
Progesterone—Dydrogesterone—Hydrocortisone—psoriasis	0.00625	0.0232	CrCrCtD
Progesterone—Prednisolone—Fluocinolone Acetonide—psoriasis	0.00619	0.023	CrCrCtD
Progesterone—CYP1A1—Methoxsalen—psoriasis	0.00596	0.0196	CbGbCtD
Progesterone—Potassium Canrenoate—Hydrocortisone—psoriasis	0.00595	0.0221	CrCrCtD
Progesterone—Spironolactone—Hydrocortisone—psoriasis	0.00595	0.0221	CrCrCtD
Progesterone—ABCB11—Cyclosporine—psoriasis	0.00591	0.0195	CbGbCtD
Progesterone—NR3C1—Triamcinolone—psoriasis	0.00574	0.0189	CbGbCtD
Progesterone—PGR—Dexamethasone—psoriasis	0.00561	0.0185	CbGbCtD
Progesterone—Levonorgestrel—Hydrocortisone—psoriasis	0.00544	0.0202	CrCrCtD
Progesterone—Megestrol acetate—Hydrocortisone—psoriasis	0.00544	0.0202	CrCrCtD
Progesterone—CYP2C8—Tazarotene—psoriasis	0.00534	0.0176	CbGbCtD
Progesterone—CYP3A5—Beclomethasone—psoriasis	0.00516	0.017	CbGbCtD
Progesterone—Potassium Canrenoate—Prednisone—psoriasis	0.00513	0.019	CrCrCtD
Progesterone—CYP1A2—Clobetasol propionate—psoriasis	0.00507	0.0167	CbGbCtD
Progesterone—Danazol—Hydrocortisone—psoriasis	0.00503	0.0186	CrCrCtD
Progesterone—Medrysone—Hydrocortisone—psoriasis	0.00503	0.0186	CrCrCtD
Progesterone—Potassium Canrenoate—Prednisolone—psoriasis	0.005	0.0186	CrCrCtD
Progesterone—NR3C1—Betamethasone—psoriasis	0.00492	0.0162	CbGbCtD
Progesterone—NR3C1—Prednisolone—psoriasis	0.00486	0.016	CbGbCtD
Progesterone—Medroxyprogesterone Acetate—Hydrocortisone—psoriasis	0.00484	0.018	CrCrCtD
Progesterone—NR3C1—Hydrocortisone—psoriasis	0.00461	0.0152	CbGbCtD
Progesterone—NR3C1—Prednisone—psoriasis	0.00459	0.0151	CbGbCtD
Progesterone—Norethindrone—Hydrocortisone—psoriasis	0.00437	0.0162	CrCrCtD
Progesterone—Hydrocortamate—Hydrocortisone—psoriasis	0.00437	0.0162	CrCrCtD
Progesterone—Danazol—Prednisone—psoriasis	0.00433	0.0161	CrCrCtD
Progesterone—Cortisone acetate—Hydrocortisone—psoriasis	0.00424	0.0157	CrCrCtD
Progesterone—Medrysone—Prednisolone—psoriasis	0.00422	0.0157	CrCrCtD
Progesterone—ABCC1—Cyclosporine—psoriasis	0.0042	0.0138	CbGbCtD
Progesterone—CYP1A1—Cholecalciferol—psoriasis	0.00395	0.013	CbGbCtD
Progesterone—ABCB11—Dexamethasone—psoriasis	0.00389	0.0128	CbGbCtD
Progesterone—CYP1B1—Dexamethasone—psoriasis	0.00389	0.0128	CbGbCtD
Progesterone—Testolactone—Betamethasone—psoriasis	0.00382	0.0142	CrCrCtD
Progesterone—Testolactone—Dexamethasone—psoriasis	0.00382	0.0142	CrCrCtD
Progesterone—Fluoxymesterone—Hydrocortisone—psoriasis	0.00378	0.014	CrCrCtD
Progesterone—Hydrocortamate—Prednisone—psoriasis	0.00376	0.014	CrCrCtD
Progesterone—Testolactone—Triamcinolone—psoriasis	0.00373	0.0138	CrCrCtD
Progesterone—Fludrocortisone—Hydrocortisone—psoriasis	0.00368	0.0136	CrCrCtD
Progesterone—Testosterone Propionate—Hydrocortisone—psoriasis	0.00368	0.0136	CrCrCtD
Progesterone—Hydrocortamate—Prednisolone—psoriasis	0.00367	0.0136	CrCrCtD
Progesterone—Cortisone acetate—Prednisone—psoriasis	0.00365	0.0135	CrCrCtD
Progesterone—Methyltestosterone—Hydrocortisone—psoriasis	0.00359	0.0133	CrCrCtD
Progesterone—Cortisone acetate—Prednisolone—psoriasis	0.00356	0.0132	CrCrCtD
Progesterone—Testolactone—Prednisone—psoriasis	0.00354	0.0131	CrCrCtD
Progesterone—Fluoxymesterone—Betamethasone—psoriasis	0.00351	0.013	CrCrCtD
Progesterone—Fluoxymesterone—Dexamethasone—psoriasis	0.00351	0.013	CrCrCtD
Progesterone—Testolactone—Prednisolone—psoriasis	0.00346	0.0128	CrCrCtD
Progesterone—Fluoxymesterone—Triamcinolone—psoriasis	0.00343	0.0127	CrCrCtD
Progesterone—Fludrocortisone—Dexamethasone—psoriasis	0.00342	0.0127	CrCrCtD
Progesterone—Fludrocortisone—Betamethasone—psoriasis	0.00342	0.0127	CrCrCtD
Progesterone—CYP2A6—Prednisolone—psoriasis	0.00339	0.0112	CbGbCtD
Progesterone—Fludrocortisone—Triamcinolone—psoriasis	0.00334	0.0124	CrCrCtD
Progesterone—Testosterone—Hydrocortisone—psoriasis	0.00319	0.0118	CrCrCtD
Progesterone—Fluoxymesterone—Prednisolone—psoriasis	0.00318	0.0118	CrCrCtD
Progesterone—Fludrocortisone—Prednisone—psoriasis	0.00317	0.0118	CrCrCtD
Progesterone—Prednisolone—Hydrocortisone—psoriasis	0.00313	0.0116	CrCrCtD
Progesterone—Fludrocortisone—Prednisolone—psoriasis	0.00309	0.0115	CrCrCtD
Progesterone—Methyltestosterone—Prednisone—psoriasis	0.00309	0.0115	CrCrCtD
Progesterone—Methyltestosterone—Prednisolone—psoriasis	0.00302	0.0112	CrCrCtD
Progesterone—Prednisolone—Betamethasone—psoriasis	0.0029	0.0108	CrCrCtD
Progesterone—Prednisolone—Dexamethasone—psoriasis	0.0029	0.0108	CrCrCtD
Progesterone—NR3C1—Dexamethasone—psoriasis	0.00286	0.00944	CbGbCtD
Progesterone—Prednisolone—Triamcinolone—psoriasis	0.00284	0.0105	CrCrCtD
Progesterone—Hydrocortisone—Betamethasone—psoriasis	0.00279	0.0103	CrCrCtD
Progesterone—Hydrocortisone—Dexamethasone—psoriasis	0.00279	0.0103	CrCrCtD
Progesterone—Hydrocortisone—Triamcinolone—psoriasis	0.00272	0.0101	CrCrCtD
Progesterone—Prednisolone—Prednisone—psoriasis	0.00269	0.00999	CrCrCtD
Progesterone—Testosterone—Prednisolone—psoriasis	0.00269	0.00996	CrCrCtD
Progesterone—CYP1A2—Methoxsalen—psoriasis	0.00266	0.00877	CbGbCtD
Progesterone—Hydrocortisone—Prednisone—psoriasis	0.00258	0.00959	CrCrCtD
Progesterone—Hydrocortisone—Prednisolone—psoriasis	0.00252	0.00936	CrCrCtD
Progesterone—CYP2D6—Hydroxyurea—psoriasis	0.0024	0.0079	CbGbCtD
Progesterone—CYP2C8—Cholecalciferol—psoriasis	0.00228	0.00751	CbGbCtD
Progesterone—ABCC1—Methotrexate—psoriasis	0.00222	0.00732	CbGbCtD
Progesterone—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.0022	0.00724	CbGbCtD
Progesterone—CYP3A7—Hydrocortisone—psoriasis	0.0022	0.00724	CbGbCtD
Progesterone—CYP3A7—Cyclosporine—psoriasis	0.00207	0.00684	CbGbCtD
Progesterone—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.00207	0.00684	CbGbCtD
Progesterone—CYP3A5—Mycophenolate mofetil—psoriasis	0.00205	0.00677	CbGbCtD
Progesterone—CYP2A6—Dexamethasone—psoriasis	0.002	0.00659	CbGbCtD
Progesterone—CYP2C8—Mycophenolate mofetil—psoriasis	0.00197	0.00651	CbGbCtD
Progesterone—CYP2C19—Cholecalciferol—psoriasis	0.00191	0.0063	CbGbCtD
Progesterone—CYP3A4—Calcitriol—psoriasis	0.00179	0.00591	CbGbCtD
Progesterone—CYP1A1—Dexamethasone—psoriasis	0.00171	0.00563	CbGbCtD
Progesterone—CYP3A5—Hydrocortisone—psoriasis	0.00165	0.00543	CbGbCtD
Progesterone—CYP2C9—Cholecalciferol—psoriasis	0.00159	0.00524	CbGbCtD
Progesterone—CYP2C8—Hydrocortisone—psoriasis	0.00158	0.00522	CbGbCtD
Progesterone—CYP3A5—Cyclosporine—psoriasis	0.00156	0.00513	CbGbCtD
Progesterone—CYP2C8—Cyclosporine—psoriasis	0.0015	0.00493	CbGbCtD
Progesterone—CYP2D6—Cholecalciferol—psoriasis	0.00145	0.00479	CbGbCtD
Progesterone—CYP3A4—Methoxsalen—psoriasis	0.00139	0.0046	CbGbCtD
Progesterone—CYP3A7—Dexamethasone—psoriasis	0.00137	0.0045	CbGbCtD
Progesterone—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.00137	0.0045	CbGbCtD
Progesterone—ABCB1—Mycophenolate mofetil—psoriasis	0.00134	0.0044	CbGbCtD
Progesterone—CYP2C19—Prednisone—psoriasis	0.00132	0.00436	CbGbCtD
Progesterone—CYP2C19—Cyclosporine—psoriasis	0.00126	0.00414	CbGbCtD
Progesterone—ABCB1—Betamethasone—psoriasis	0.00115	0.00378	CbGbCtD
Progesterone—ABCB1—Prednisolone—psoriasis	0.00113	0.00373	CbGbCtD
Progesterone—ABCB1—Hydrocortisone—psoriasis	0.00107	0.00354	CbGbCtD
Progesterone—ABCB1—Prednisone—psoriasis	0.00107	0.00352	CbGbCtD
Progesterone—CYP2C9—Cyclosporine—psoriasis	0.00104	0.00344	CbGbCtD
Progesterone—CYP3A5—Dexamethasone—psoriasis	0.00102	0.00338	CbGbCtD
Progesterone—ABCB1—Cyclosporine—psoriasis	0.00101	0.00334	CbGbCtD
Progesterone—CYP2C8—Dexamethasone—psoriasis	0.000985	0.00325	CbGbCtD
Progesterone—CYP2D6—Cyclosporine—psoriasis	0.000954	0.00315	CbGbCtD
Progesterone—CYP3A4—Cholecalciferol—psoriasis	0.000924	0.00304	CbGbCtD
Progesterone—CYP2C19—Dexamethasone—psoriasis	0.000827	0.00272	CbGbCtD
Progesterone—CYP3A4—Triamcinolone—psoriasis	0.000801	0.00264	CbGbCtD
Progesterone—CYP3A4—Mycophenolate mofetil—psoriasis	0.000801	0.00264	CbGbCtD
Progesterone—CYP2C9—Dexamethasone—psoriasis	0.000687	0.00227	CbGbCtD
Progesterone—CYP3A4—Betamethasone—psoriasis	0.000687	0.00226	CbGbCtD
Progesterone—CYP3A4—Prednisolone—psoriasis	0.000678	0.00223	CbGbCtD
Progesterone—ABCB1—Dexamethasone—psoriasis	0.000667	0.0022	CbGbCtD
Progesterone—CYP3A4—Hydrocortisone—psoriasis	0.000643	0.00212	CbGbCtD
Progesterone—CYP3A4—Prednisone—psoriasis	0.00064	0.00211	CbGbCtD
Progesterone—CYP2D6—Dexamethasone—psoriasis	0.000629	0.00207	CbGbCtD
Progesterone—CYP3A4—Cyclosporine—psoriasis	0.000607	0.002	CbGbCtD
Progesterone—ABCB1—Methotrexate—psoriasis	0.000536	0.00177	CbGbCtD
Progesterone—CYP3A4—Dexamethasone—psoriasis	0.0004	0.00132	CbGbCtD
Progesterone—SIGMAR1—Levonorgestrel—Hydrocortisone—psoriasis	0.000171	1	CbGdCrCtD
Progesterone—Vomiting—Mycophenolic acid—psoriasis	1.86e-05	0.000261	CcSEcCtD
Progesterone—Discomfort—Dexamethasone—psoriasis	1.85e-05	0.00026	CcSEcCtD
Progesterone—Discomfort—Betamethasone—psoriasis	1.85e-05	0.00026	CcSEcCtD
Progesterone—Dyspepsia—Hydrocortisone—psoriasis	1.85e-05	0.00026	CcSEcCtD
Progesterone—Haemoglobin—Methotrexate—psoriasis	1.85e-05	0.00026	CcSEcCtD
Progesterone—Rash—Mycophenolic acid—psoriasis	1.85e-05	0.000259	CcSEcCtD
Progesterone—Dermatitis—Mycophenolic acid—psoriasis	1.85e-05	0.000259	CcSEcCtD
Progesterone—Pain—Prednisolone—psoriasis	1.84e-05	0.000258	CcSEcCtD
Progesterone—Hepatitis—Methotrexate—psoriasis	1.84e-05	0.000258	CcSEcCtD
Progesterone—Haemorrhage—Methotrexate—psoriasis	1.84e-05	0.000258	CcSEcCtD
Progesterone—Urticaria—Mycophenolate mofetil—psoriasis	1.84e-05	0.000257	CcSEcCtD
Progesterone—Headache—Mycophenolic acid—psoriasis	1.84e-05	0.000257	CcSEcCtD
Progesterone—Decreased appetite—Hydrocortisone—psoriasis	1.83e-05	0.000257	CcSEcCtD
Progesterone—Pharyngitis—Methotrexate—psoriasis	1.83e-05	0.000256	CcSEcCtD
Progesterone—Abdominal pain—Mycophenolate mofetil—psoriasis	1.83e-05	0.000256	CcSEcCtD
Progesterone—Body temperature increased—Mycophenolate mofetil—psoriasis	1.83e-05	0.000256	CcSEcCtD
Progesterone—Urinary tract disorder—Methotrexate—psoriasis	1.82e-05	0.000255	CcSEcCtD
Progesterone—Gastrointestinal disorder—Hydrocortisone—psoriasis	1.82e-05	0.000255	CcSEcCtD
Progesterone—Fatigue—Hydrocortisone—psoriasis	1.82e-05	0.000255	CcSEcCtD
Progesterone—Vision blurred—Prednisone—psoriasis	1.81e-05	0.000254	CcSEcCtD
Progesterone—Urethral disorder—Methotrexate—psoriasis	1.81e-05	0.000253	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Triamcinolone—psoriasis	1.81e-05	0.000253	CcSEcCtD
Progesterone—Pain—Hydrocortisone—psoriasis	1.8e-05	0.000252	CcSEcCtD
Progesterone—Anaphylactic shock—Betamethasone—psoriasis	1.8e-05	0.000252	CcSEcCtD
Progesterone—Anaphylactic shock—Dexamethasone—psoriasis	1.8e-05	0.000252	CcSEcCtD
Progesterone—Oedema—Betamethasone—psoriasis	1.8e-05	0.000252	CcSEcCtD
Progesterone—Oedema—Dexamethasone—psoriasis	1.8e-05	0.000252	CcSEcCtD
Progesterone—Insomnia—Triamcinolone—psoriasis	1.79e-05	0.000251	CcSEcCtD
Progesterone—Infection—Betamethasone—psoriasis	1.79e-05	0.000251	CcSEcCtD
Progesterone—Infection—Dexamethasone—psoriasis	1.79e-05	0.000251	CcSEcCtD
Progesterone—Ill-defined disorder—Prednisone—psoriasis	1.78e-05	0.00025	CcSEcCtD
Progesterone—Paraesthesia—Triamcinolone—psoriasis	1.78e-05	0.00025	CcSEcCtD
Progesterone—Feeling abnormal—Prednisolone—psoriasis	1.78e-05	0.000249	CcSEcCtD
Progesterone—Visual impairment—Methotrexate—psoriasis	1.78e-05	0.000249	CcSEcCtD
Progesterone—Anaemia—Prednisone—psoriasis	1.77e-05	0.000249	CcSEcCtD
Progesterone—Shock—Dexamethasone—psoriasis	1.77e-05	0.000248	CcSEcCtD
Progesterone—Shock—Betamethasone—psoriasis	1.77e-05	0.000248	CcSEcCtD
Progesterone—Dyspnoea—Triamcinolone—psoriasis	1.77e-05	0.000248	CcSEcCtD
Progesterone—Nervous system disorder—Betamethasone—psoriasis	1.76e-05	0.000247	CcSEcCtD
Progesterone—Nervous system disorder—Dexamethasone—psoriasis	1.76e-05	0.000247	CcSEcCtD
Progesterone—Tachycardia—Betamethasone—psoriasis	1.76e-05	0.000246	CcSEcCtD
Progesterone—Tachycardia—Dexamethasone—psoriasis	1.76e-05	0.000246	CcSEcCtD
Progesterone—Angioedema—Prednisone—psoriasis	1.75e-05	0.000246	CcSEcCtD
Progesterone—Hypersensitivity—Cyclosporine—psoriasis	1.75e-05	0.000245	CcSEcCtD
Progesterone—Dyspepsia—Triamcinolone—psoriasis	1.75e-05	0.000245	CcSEcCtD
Progesterone—Erythema multiforme—Methotrexate—psoriasis	1.74e-05	0.000244	CcSEcCtD
Progesterone—Nausea—Mycophenolic acid—psoriasis	1.74e-05	0.000244	CcSEcCtD
Progesterone—Hyperhidrosis—Dexamethasone—psoriasis	1.74e-05	0.000244	CcSEcCtD
Progesterone—Hyperhidrosis—Betamethasone—psoriasis	1.74e-05	0.000244	CcSEcCtD
Progesterone—Feeling abnormal—Hydrocortisone—psoriasis	1.74e-05	0.000243	CcSEcCtD
Progesterone—Malaise—Prednisone—psoriasis	1.73e-05	0.000243	CcSEcCtD
Progesterone—Vertigo—Prednisone—psoriasis	1.73e-05	0.000242	CcSEcCtD
Progesterone—Eye disorder—Methotrexate—psoriasis	1.72e-05	0.000241	CcSEcCtD
Progesterone—Gastrointestinal pain—Hydrocortisone—psoriasis	1.72e-05	0.000241	CcSEcCtD
Progesterone—Syncope—Prednisone—psoriasis	1.72e-05	0.000241	CcSEcCtD
Progesterone—Tinnitus—Methotrexate—psoriasis	1.72e-05	0.000241	CcSEcCtD
Progesterone—Anorexia—Dexamethasone—psoriasis	1.72e-05	0.00024	CcSEcCtD
Progesterone—Anorexia—Betamethasone—psoriasis	1.72e-05	0.00024	CcSEcCtD
Progesterone—Urticaria—Prednisolone—psoriasis	1.71e-05	0.00024	CcSEcCtD
Progesterone—Cardiac disorder—Methotrexate—psoriasis	1.71e-05	0.00024	CcSEcCtD
Progesterone—Fatigue—Triamcinolone—psoriasis	1.71e-05	0.00024	CcSEcCtD
Progesterone—Hypersensitivity—Mycophenolate mofetil—psoriasis	1.7e-05	0.000239	CcSEcCtD
Progesterone—Asthenia—Cyclosporine—psoriasis	1.7e-05	0.000238	CcSEcCtD
Progesterone—Pain—Triamcinolone—psoriasis	1.7e-05	0.000238	CcSEcCtD
Progesterone—Loss of consciousness—Prednisone—psoriasis	1.69e-05	0.000237	CcSEcCtD
Progesterone—Hypotension—Dexamethasone—psoriasis	1.68e-05	0.000236	CcSEcCtD
Progesterone—Hypotension—Betamethasone—psoriasis	1.68e-05	0.000236	CcSEcCtD
Progesterone—Pruritus—Cyclosporine—psoriasis	1.68e-05	0.000235	CcSEcCtD
Progesterone—Urticaria—Hydrocortisone—psoriasis	1.67e-05	0.000235	CcSEcCtD
Progesterone—Angiopathy—Methotrexate—psoriasis	1.67e-05	0.000234	CcSEcCtD
Progesterone—Immune system disorder—Methotrexate—psoriasis	1.67e-05	0.000233	CcSEcCtD
Progesterone—Abdominal pain—Hydrocortisone—psoriasis	1.67e-05	0.000233	CcSEcCtD
Progesterone—Body temperature increased—Hydrocortisone—psoriasis	1.67e-05	0.000233	CcSEcCtD
Progesterone—Convulsion—Prednisone—psoriasis	1.66e-05	0.000233	CcSEcCtD
Progesterone—Mediastinal disorder—Methotrexate—psoriasis	1.66e-05	0.000233	CcSEcCtD
Progesterone—Asthenia—Mycophenolate mofetil—psoriasis	1.66e-05	0.000232	CcSEcCtD
Progesterone—Hypertension—Prednisone—psoriasis	1.66e-05	0.000232	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Dexamethasone—psoriasis	1.64e-05	0.00023	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Betamethasone—psoriasis	1.64e-05	0.00023	CcSEcCtD
Progesterone—Pruritus—Mycophenolate mofetil—psoriasis	1.64e-05	0.000229	CcSEcCtD
Progesterone—Myalgia—Prednisone—psoriasis	1.63e-05	0.000229	CcSEcCtD
Progesterone—Arthralgia—Prednisone—psoriasis	1.63e-05	0.000229	CcSEcCtD
Progesterone—Feeling abnormal—Triamcinolone—psoriasis	1.63e-05	0.000229	CcSEcCtD
Progesterone—Anxiety—Prednisone—psoriasis	1.63e-05	0.000228	CcSEcCtD
Progesterone—Alopecia—Methotrexate—psoriasis	1.63e-05	0.000228	CcSEcCtD
Progesterone—Insomnia—Dexamethasone—psoriasis	1.63e-05	0.000228	CcSEcCtD
Progesterone—Insomnia—Betamethasone—psoriasis	1.63e-05	0.000228	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	1.62e-05	0.000228	CcSEcCtD
Progesterone—Diarrhoea—Cyclosporine—psoriasis	1.62e-05	0.000227	CcSEcCtD
Progesterone—Paraesthesia—Dexamethasone—psoriasis	1.62e-05	0.000226	CcSEcCtD
Progesterone—Paraesthesia—Betamethasone—psoriasis	1.62e-05	0.000226	CcSEcCtD
Progesterone—Discomfort—Prednisone—psoriasis	1.62e-05	0.000226	CcSEcCtD
Progesterone—Mental disorder—Methotrexate—psoriasis	1.62e-05	0.000226	CcSEcCtD
Progesterone—Malnutrition—Methotrexate—psoriasis	1.6e-05	0.000225	CcSEcCtD
Progesterone—Erythema—Methotrexate—psoriasis	1.6e-05	0.000225	CcSEcCtD
Progesterone—Hypersensitivity—Prednisolone—psoriasis	1.59e-05	0.000223	CcSEcCtD
Progesterone—Dyspepsia—Betamethasone—psoriasis	1.58e-05	0.000222	CcSEcCtD
Progesterone—Dyspepsia—Dexamethasone—psoriasis	1.58e-05	0.000222	CcSEcCtD
Progesterone—Diarrhoea—Mycophenolate mofetil—psoriasis	1.58e-05	0.000222	CcSEcCtD
Progesterone—Urticaria—Triamcinolone—psoriasis	1.58e-05	0.000221	CcSEcCtD
Progesterone—Body temperature increased—Triamcinolone—psoriasis	1.57e-05	0.00022	CcSEcCtD
Progesterone—Dizziness—Cyclosporine—psoriasis	1.57e-05	0.00022	CcSEcCtD
Progesterone—Oedema—Prednisone—psoriasis	1.57e-05	0.00022	CcSEcCtD
Progesterone—Anaphylactic shock—Prednisone—psoriasis	1.57e-05	0.00022	CcSEcCtD
Progesterone—Decreased appetite—Dexamethasone—psoriasis	1.56e-05	0.000219	CcSEcCtD
Progesterone—Decreased appetite—Betamethasone—psoriasis	1.56e-05	0.000219	CcSEcCtD
Progesterone—Infection—Prednisone—psoriasis	1.56e-05	0.000218	CcSEcCtD
Progesterone—Gastrointestinal disorder—Betamethasone—psoriasis	1.55e-05	0.000218	CcSEcCtD
Progesterone—Gastrointestinal disorder—Dexamethasone—psoriasis	1.55e-05	0.000218	CcSEcCtD
Progesterone—Back pain—Methotrexate—psoriasis	1.55e-05	0.000218	CcSEcCtD
Progesterone—Hypersensitivity—Hydrocortisone—psoriasis	1.55e-05	0.000217	CcSEcCtD
Progesterone—Fatigue—Dexamethasone—psoriasis	1.55e-05	0.000217	CcSEcCtD
Progesterone—Fatigue—Betamethasone—psoriasis	1.55e-05	0.000217	CcSEcCtD
Progesterone—Shock—Prednisone—psoriasis	1.54e-05	0.000216	CcSEcCtD
Progesterone—Pain—Betamethasone—psoriasis	1.54e-05	0.000216	CcSEcCtD
Progesterone—Pain—Dexamethasone—psoriasis	1.54e-05	0.000216	CcSEcCtD
Progesterone—Nervous system disorder—Prednisone—psoriasis	1.54e-05	0.000215	CcSEcCtD
Progesterone—Tachycardia—Prednisone—psoriasis	1.53e-05	0.000214	CcSEcCtD
Progesterone—Dizziness—Mycophenolate mofetil—psoriasis	1.53e-05	0.000214	CcSEcCtD
Progesterone—Skin disorder—Prednisone—psoriasis	1.52e-05	0.000213	CcSEcCtD
Progesterone—Hyperhidrosis—Prednisone—psoriasis	1.52e-05	0.000212	CcSEcCtD
Progesterone—Vision blurred—Methotrexate—psoriasis	1.51e-05	0.000212	CcSEcCtD
Progesterone—Asthenia—Hydrocortisone—psoriasis	1.51e-05	0.000212	CcSEcCtD
Progesterone—Vomiting—Cyclosporine—psoriasis	1.51e-05	0.000211	CcSEcCtD
Progesterone—Rash—Cyclosporine—psoriasis	1.49e-05	0.000209	CcSEcCtD
Progesterone—Anorexia—Prednisone—psoriasis	1.49e-05	0.000209	CcSEcCtD
Progesterone—Dermatitis—Cyclosporine—psoriasis	1.49e-05	0.000209	CcSEcCtD
Progesterone—Pruritus—Hydrocortisone—psoriasis	1.49e-05	0.000209	CcSEcCtD
Progesterone—Ill-defined disorder—Methotrexate—psoriasis	1.49e-05	0.000209	CcSEcCtD
Progesterone—Headache—Cyclosporine—psoriasis	1.48e-05	0.000208	CcSEcCtD
Progesterone—Anaemia—Methotrexate—psoriasis	1.48e-05	0.000208	CcSEcCtD
Progesterone—Feeling abnormal—Dexamethasone—psoriasis	1.48e-05	0.000208	CcSEcCtD
Progesterone—Feeling abnormal—Betamethasone—psoriasis	1.48e-05	0.000208	CcSEcCtD
Progesterone—Gastrointestinal pain—Dexamethasone—psoriasis	1.47e-05	0.000206	CcSEcCtD
Progesterone—Gastrointestinal pain—Betamethasone—psoriasis	1.47e-05	0.000206	CcSEcCtD
Progesterone—Vomiting—Mycophenolate mofetil—psoriasis	1.47e-05	0.000206	CcSEcCtD
Progesterone—Hypersensitivity—Triamcinolone—psoriasis	1.46e-05	0.000205	CcSEcCtD
Progesterone—Rash—Mycophenolate mofetil—psoriasis	1.46e-05	0.000204	CcSEcCtD
Progesterone—Dermatitis—Mycophenolate mofetil—psoriasis	1.46e-05	0.000204	CcSEcCtD
Progesterone—Headache—Mycophenolate mofetil—psoriasis	1.45e-05	0.000203	CcSEcCtD
Progesterone—Malaise—Methotrexate—psoriasis	1.45e-05	0.000203	CcSEcCtD
Progesterone—Vertigo—Methotrexate—psoriasis	1.44e-05	0.000202	CcSEcCtD
Progesterone—Diarrhoea—Hydrocortisone—psoriasis	1.44e-05	0.000202	CcSEcCtD
Progesterone—Urticaria—Betamethasone—psoriasis	1.43e-05	0.0002	CcSEcCtD
Progesterone—Urticaria—Dexamethasone—psoriasis	1.43e-05	0.0002	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Prednisone—psoriasis	1.43e-05	0.0002	CcSEcCtD
Progesterone—Dizziness—Prednisolone—psoriasis	1.43e-05	0.0002	CcSEcCtD
Progesterone—Asthenia—Triamcinolone—psoriasis	1.42e-05	0.000199	CcSEcCtD
Progesterone—Abdominal pain—Betamethasone—psoriasis	1.42e-05	0.000199	CcSEcCtD
Progesterone—Abdominal pain—Dexamethasone—psoriasis	1.42e-05	0.000199	CcSEcCtD
Progesterone—Body temperature increased—Dexamethasone—psoriasis	1.42e-05	0.000199	CcSEcCtD
Progesterone—Body temperature increased—Betamethasone—psoriasis	1.42e-05	0.000199	CcSEcCtD
Progesterone—Insomnia—Prednisone—psoriasis	1.42e-05	0.000199	CcSEcCtD
Progesterone—Nausea—Cyclosporine—psoriasis	1.41e-05	0.000197	CcSEcCtD
Progesterone—Paraesthesia—Prednisone—psoriasis	1.41e-05	0.000197	CcSEcCtD
Progesterone—Pruritus—Triamcinolone—psoriasis	1.4e-05	0.000197	CcSEcCtD
Progesterone—Cough—Methotrexate—psoriasis	1.4e-05	0.000196	CcSEcCtD
Progesterone—Dizziness—Hydrocortisone—psoriasis	1.39e-05	0.000195	CcSEcCtD
Progesterone—Convulsion—Methotrexate—psoriasis	1.39e-05	0.000195	CcSEcCtD
Progesterone—Dyspepsia—Prednisone—psoriasis	1.38e-05	0.000193	CcSEcCtD
Progesterone—Nausea—Mycophenolate mofetil—psoriasis	1.37e-05	0.000192	CcSEcCtD
Progesterone—Chest pain—Methotrexate—psoriasis	1.37e-05	0.000191	CcSEcCtD
Progesterone—Myalgia—Methotrexate—psoriasis	1.37e-05	0.000191	CcSEcCtD
Progesterone—Arthralgia—Methotrexate—psoriasis	1.37e-05	0.000191	CcSEcCtD
Progesterone—Decreased appetite—Prednisone—psoriasis	1.36e-05	0.000191	CcSEcCtD
Progesterone—Rash—Prednisolone—psoriasis	1.36e-05	0.000191	CcSEcCtD
Progesterone—Dermatitis—Prednisolone—psoriasis	1.36e-05	0.00019	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	1.36e-05	0.00019	CcSEcCtD
Progesterone—Fatigue—Prednisone—psoriasis	1.35e-05	0.000189	CcSEcCtD
Progesterone—Headache—Prednisolone—psoriasis	1.35e-05	0.000189	CcSEcCtD
Progesterone—Discomfort—Methotrexate—psoriasis	1.35e-05	0.000189	CcSEcCtD
Progesterone—Constipation—Prednisone—psoriasis	1.34e-05	0.000188	CcSEcCtD
Progesterone—Vomiting—Hydrocortisone—psoriasis	1.34e-05	0.000188	CcSEcCtD
Progesterone—Rash—Hydrocortisone—psoriasis	1.33e-05	0.000186	CcSEcCtD
Progesterone—Dermatitis—Hydrocortisone—psoriasis	1.33e-05	0.000186	CcSEcCtD
Progesterone—Confusional state—Methotrexate—psoriasis	1.32e-05	0.000185	CcSEcCtD
Progesterone—Headache—Hydrocortisone—psoriasis	1.32e-05	0.000185	CcSEcCtD
Progesterone—Dizziness—Triamcinolone—psoriasis	1.31e-05	0.000184	CcSEcCtD
Progesterone—Anaphylactic shock—Methotrexate—psoriasis	1.31e-05	0.000184	CcSEcCtD
Progesterone—Infection—Methotrexate—psoriasis	1.3e-05	0.000182	CcSEcCtD
Progesterone—Feeling abnormal—Prednisone—psoriasis	1.29e-05	0.000181	CcSEcCtD
Progesterone—Asthenia—Betamethasone—psoriasis	1.29e-05	0.000181	CcSEcCtD
Progesterone—Asthenia—Dexamethasone—psoriasis	1.29e-05	0.000181	CcSEcCtD
Progesterone—Nervous system disorder—Methotrexate—psoriasis	1.28e-05	0.00018	CcSEcCtD
Progesterone—Gastrointestinal pain—Prednisone—psoriasis	1.28e-05	0.00018	CcSEcCtD
Progesterone—Nausea—Prednisolone—psoriasis	1.28e-05	0.00018	CcSEcCtD
Progesterone—Pruritus—Betamethasone—psoriasis	1.27e-05	0.000178	CcSEcCtD
Progesterone—Pruritus—Dexamethasone—psoriasis	1.27e-05	0.000178	CcSEcCtD
Progesterone—Skin disorder—Methotrexate—psoriasis	1.27e-05	0.000178	CcSEcCtD
Progesterone—Hyperhidrosis—Methotrexate—psoriasis	1.27e-05	0.000177	CcSEcCtD
Progesterone—AR—SIDS Susceptibility Pathways—VEGFA—psoriasis	1.27e-05	0.000521	CbGpPWpGaD
Progesterone—NR3C1—AP-1 transcription factor network—IL6—psoriasis	1.26e-05	0.000519	CbGpPWpGaD
Progesterone—Vomiting—Triamcinolone—psoriasis	1.26e-05	0.000177	CcSEcCtD
Progesterone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	1.25e-05	0.000516	CbGpPWpGaD
Progesterone—Nausea—Hydrocortisone—psoriasis	1.25e-05	0.000175	CcSEcCtD
Progesterone—Rash—Triamcinolone—psoriasis	1.25e-05	0.000175	CcSEcCtD
Progesterone—Dermatitis—Triamcinolone—psoriasis	1.25e-05	0.000175	CcSEcCtD
Progesterone—Anorexia—Methotrexate—psoriasis	1.25e-05	0.000175	CcSEcCtD
Progesterone—Urticaria—Prednisone—psoriasis	1.25e-05	0.000174	CcSEcCtD
Progesterone—Headache—Triamcinolone—psoriasis	1.24e-05	0.000174	CcSEcCtD
Progesterone—Abdominal pain—Prednisone—psoriasis	1.24e-05	0.000174	CcSEcCtD
Progesterone—Body temperature increased—Prednisone—psoriasis	1.24e-05	0.000174	CcSEcCtD
Progesterone—AR—Generic Transcription Pathway—VDR—psoriasis	1.24e-05	0.00051	CbGpPWpGaD
Progesterone—SLC22A2—Transmembrane transport of small molecules—CARM1—psoriasis	1.24e-05	0.000509	CbGpPWpGaD
Progesterone—AR—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.23e-05	0.000507	CbGpPWpGaD
Progesterone—Diarrhoea—Betamethasone—psoriasis	1.23e-05	0.000173	CcSEcCtD
Progesterone—Diarrhoea—Dexamethasone—psoriasis	1.23e-05	0.000173	CcSEcCtD
Progesterone—Hypotension—Methotrexate—psoriasis	1.22e-05	0.000172	CcSEcCtD
Progesterone—NR3C1—Glucocorticoid receptor regulatory network—TP53—psoriasis	1.21e-05	0.0005	CbGpPWpGaD
Progesterone—SLC22A1—Transmembrane transport of small molecules—CP—psoriasis	1.21e-05	0.000497	CbGpPWpGaD
Progesterone—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	1.21e-05	0.000496	CbGpPWpGaD
Progesterone—Musculoskeletal discomfort—Methotrexate—psoriasis	1.19e-05	0.000167	CcSEcCtD
Progesterone—Dizziness—Dexamethasone—psoriasis	1.19e-05	0.000167	CcSEcCtD
Progesterone—Dizziness—Betamethasone—psoriasis	1.19e-05	0.000167	CcSEcCtD
Progesterone—CYP3A7—Metabolism—CYP2S1—psoriasis	1.19e-05	0.000489	CbGpPWpGaD
Progesterone—AR—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.19e-05	0.000488	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—CYP2S1—psoriasis	1.19e-05	0.000488	CbGpPWpGaD
Progesterone—Insomnia—Methotrexate—psoriasis	1.18e-05	0.000166	CcSEcCtD
Progesterone—CYP17A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.18e-05	0.000487	CbGpPWpGaD
Progesterone—NR3C1—SIDS Susceptibility Pathways—CXCL8—psoriasis	1.18e-05	0.000487	CbGpPWpGaD
Progesterone—Nausea—Triamcinolone—psoriasis	1.18e-05	0.000165	CcSEcCtD
Progesterone—ABCB1—Allograft Rejection—IFNG—psoriasis	1.18e-05	0.000485	CbGpPWpGaD
Progesterone—Paraesthesia—Methotrexate—psoriasis	1.18e-05	0.000165	CcSEcCtD
Progesterone—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	1.18e-05	0.000484	CbGpPWpGaD
Progesterone—PGR—Signaling by ERBB4—IL6—psoriasis	1.17e-05	0.000483	CbGpPWpGaD
Progesterone—Dyspnoea—Methotrexate—psoriasis	1.17e-05	0.000164	CcSEcCtD
Progesterone—Somnolence—Methotrexate—psoriasis	1.16e-05	0.000163	CcSEcCtD
Progesterone—OPRK1—G alpha (i) signalling events—CXCL8—psoriasis	1.15e-05	0.000475	CbGpPWpGaD
Progesterone—Hypersensitivity—Prednisone—psoriasis	1.15e-05	0.000162	CcSEcCtD
Progesterone—Dyspepsia—Methotrexate—psoriasis	1.15e-05	0.000162	CcSEcCtD
Progesterone—SLC22A1—Transmembrane transport of small molecules—CARM1—psoriasis	1.15e-05	0.000474	CbGpPWpGaD
Progesterone—ESR1—Integrated Breast Cancer Pathway—JUN—psoriasis	1.15e-05	0.000472	CbGpPWpGaD
Progesterone—Vomiting—Betamethasone—psoriasis	1.14e-05	0.00016	CcSEcCtD
Progesterone—Vomiting—Dexamethasone—psoriasis	1.14e-05	0.00016	CcSEcCtD
Progesterone—Decreased appetite—Methotrexate—psoriasis	1.14e-05	0.00016	CcSEcCtD
Progesterone—Rash—Betamethasone—psoriasis	1.13e-05	0.000159	CcSEcCtD
Progesterone—Rash—Dexamethasone—psoriasis	1.13e-05	0.000159	CcSEcCtD
Progesterone—Dermatitis—Betamethasone—psoriasis	1.13e-05	0.000159	CcSEcCtD
Progesterone—Dermatitis—Dexamethasone—psoriasis	1.13e-05	0.000159	CcSEcCtD
Progesterone—PGR—Generic Transcription Pathway—PPARG—psoriasis	1.13e-05	0.000466	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—HCAR2—psoriasis	1.13e-05	0.000466	CbGpPWpGaD
Progesterone—Gastrointestinal disorder—Methotrexate—psoriasis	1.13e-05	0.000158	CcSEcCtD
Progesterone—Fatigue—Methotrexate—psoriasis	1.13e-05	0.000158	CcSEcCtD
Progesterone—Headache—Dexamethasone—psoriasis	1.13e-05	0.000158	CcSEcCtD
Progesterone—Headache—Betamethasone—psoriasis	1.13e-05	0.000158	CcSEcCtD
Progesterone—Asthenia—Prednisone—psoriasis	1.12e-05	0.000158	CcSEcCtD
Progesterone—Pain—Methotrexate—psoriasis	1.12e-05	0.000157	CcSEcCtD
Progesterone—NR3C1—Glucocorticoid receptor regulatory network—IL6—psoriasis	1.11e-05	0.000457	CbGpPWpGaD
Progesterone—Pruritus—Prednisone—psoriasis	1.11e-05	0.000155	CcSEcCtD
Progesterone—SLC22A1—Metabolism—CYP2S1—psoriasis	1.11e-05	0.000455	CbGpPWpGaD
Progesterone—ESR1—Integrated Breast Cancer Pathway—NFKB1—psoriasis	1.1e-05	0.000454	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—CARM1—psoriasis	1.1e-05	0.000454	CbGpPWpGaD
Progesterone—NR3C1—Adipogenesis—STAT3—psoriasis	1.1e-05	0.000453	CbGpPWpGaD
Progesterone—NR3C1—SIDS Susceptibility Pathways—JUN—psoriasis	1.1e-05	0.000453	CbGpPWpGaD
Progesterone—ABCB1—Allograft Rejection—CXCL8—psoriasis	1.1e-05	0.000451	CbGpPWpGaD
Progesterone—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	1.09e-05	0.00045	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—CYP2S1—psoriasis	1.09e-05	0.000448	CbGpPWpGaD
Progesterone—AR—SIDS Susceptibility Pathways—TNF—psoriasis	1.09e-05	0.000447	CbGpPWpGaD
Progesterone—Feeling abnormal—Methotrexate—psoriasis	1.08e-05	0.000151	CcSEcCtD
Progesterone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.08e-05	0.000443	CbGpPWpGaD
Progesterone—Diarrhoea—Prednisone—psoriasis	1.07e-05	0.00015	CcSEcCtD
Progesterone—Gastrointestinal pain—Methotrexate—psoriasis	1.07e-05	0.00015	CcSEcCtD
Progesterone—Nausea—Dexamethasone—psoriasis	1.07e-05	0.00015	CcSEcCtD
Progesterone—Nausea—Betamethasone—psoriasis	1.07e-05	0.00015	CcSEcCtD
Progesterone—NR3C1—SIDS Susceptibility Pathways—NFKB1—psoriasis	1.06e-05	0.000436	CbGpPWpGaD
Progesterone—Urticaria—Methotrexate—psoriasis	1.04e-05	0.000146	CcSEcCtD
Progesterone—Dizziness—Prednisone—psoriasis	1.04e-05	0.000145	CcSEcCtD
Progesterone—Abdominal pain—Methotrexate—psoriasis	1.04e-05	0.000145	CcSEcCtD
Progesterone—Body temperature increased—Methotrexate—psoriasis	1.04e-05	0.000145	CcSEcCtD
Progesterone—CYP17A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.03e-05	0.000424	CbGpPWpGaD
Progesterone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	1.03e-05	0.000423	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—NDUFA5—psoriasis	1.01e-05	0.000416	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—CCL20—psoriasis	1e-05	0.000412	CbGpPWpGaD
Progesterone—ESR1—Integrated Breast Cancer Pathway—VEGFA—psoriasis	1e-05	0.000412	CbGpPWpGaD
Progesterone—AR—Gene Expression—CARM1—psoriasis	9.98e-06	0.000411	CbGpPWpGaD
Progesterone—Vomiting—Prednisone—psoriasis	9.96e-06	0.00014	CcSEcCtD
Progesterone—Rash—Prednisone—psoriasis	9.88e-06	0.000138	CcSEcCtD
Progesterone—Dermatitis—Prednisone—psoriasis	9.87e-06	0.000138	CcSEcCtD
Progesterone—AR—Integrated Breast Cancer Pathway—TP53—psoriasis	9.82e-06	0.000404	CbGpPWpGaD
Progesterone—Headache—Prednisone—psoriasis	9.82e-06	0.000138	CcSEcCtD
Progesterone—ESR1—Signaling Pathways—TAGAP—psoriasis	9.82e-06	0.000404	CbGpPWpGaD
Progesterone—Hypersensitivity—Methotrexate—psoriasis	9.65e-06	0.000135	CcSEcCtD
Progesterone—NR3C1—SIDS Susceptibility Pathways—VEGFA—psoriasis	9.61e-06	0.000395	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—NDUFA5—psoriasis	9.54e-06	0.000393	CbGpPWpGaD
Progesterone—ESR1—Generic Transcription Pathway—VDR—psoriasis	9.54e-06	0.000393	CbGpPWpGaD
Progesterone—NR3C1—Adipogenesis—TNF—psoriasis	9.53e-06	0.000392	CbGpPWpGaD
Progesterone—ABCB11—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.5e-06	0.000391	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	9.5e-06	0.000391	CbGpPWpGaD
Progesterone—Asthenia—Methotrexate—psoriasis	9.4e-06	0.000132	CcSEcCtD
Progesterone—NR3C1—Generic Transcription Pathway—VDR—psoriasis	9.39e-06	0.000387	CbGpPWpGaD
Progesterone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	9.38e-06	0.000386	CbGpPWpGaD
Progesterone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	9.38e-06	0.000386	CbGpPWpGaD
Progesterone—Nausea—Prednisone—psoriasis	9.31e-06	0.00013	CcSEcCtD
Progesterone—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	9.3e-06	0.000383	CbGpPWpGaD
Progesterone—Pruritus—Methotrexate—psoriasis	9.27e-06	0.00013	CcSEcCtD
Progesterone—SLC10A1—Metabolism—CAT—psoriasis	9.24e-06	0.00038	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—CARM1—psoriasis	9.24e-06	0.00038	CbGpPWpGaD
Progesterone—AR—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	9.23e-06	0.00038	CbGpPWpGaD
Progesterone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	9.18e-06	0.000378	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	9.14e-06	0.000376	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	9.02e-06	0.000371	CbGpPWpGaD
Progesterone—Diarrhoea—Methotrexate—psoriasis	8.96e-06	0.000126	CcSEcCtD
Progesterone—NR3C2—Gene Expression—PPARG—psoriasis	8.96e-06	0.000369	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	8.9e-06	0.000366	CbGpPWpGaD
Progesterone—ABCB1—Allograft Rejection—VEGFA—psoriasis	8.89e-06	0.000366	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—CARM1—psoriasis	8.85e-06	0.000364	CbGpPWpGaD
Progesterone—AR—SIDS Susceptibility Pathways—IL6—psoriasis	8.76e-06	0.00036	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—NDUFA5—psoriasis	8.75e-06	0.00036	CbGpPWpGaD
Progesterone—Dizziness—Methotrexate—psoriasis	8.66e-06	0.000121	CcSEcCtD
Progesterone—AR—Generic Transcription Pathway—PPARG—psoriasis	8.63e-06	0.000355	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—CYP2S1—psoriasis	8.59e-06	0.000353	CbGpPWpGaD
Progesterone—Vomiting—Methotrexate—psoriasis	8.33e-06	0.000117	CcSEcCtD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	8.3e-06	0.000341	CbGpPWpGaD
Progesterone—ABCB11—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.28e-06	0.000341	CbGpPWpGaD
Progesterone—Rash—Methotrexate—psoriasis	8.26e-06	0.000116	CcSEcCtD
Progesterone—Dermatitis—Methotrexate—psoriasis	8.25e-06	0.000116	CcSEcCtD
Progesterone—NR3C1—SIDS Susceptibility Pathways—TNF—psoriasis	8.23e-06	0.000339	CbGpPWpGaD
Progesterone—Headache—Methotrexate—psoriasis	8.21e-06	0.000115	CcSEcCtD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	8.16e-06	0.000336	CbGpPWpGaD
Progesterone—AR—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	8.14e-06	0.000335	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—CYP2S1—psoriasis	8.11e-06	0.000334	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CCL20—psoriasis	7.85e-06	0.000323	CbGpPWpGaD
Progesterone—PGR—Gene Expression—VDR—psoriasis	7.83e-06	0.000322	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—NDUFA5—psoriasis	7.81e-06	0.000321	CbGpPWpGaD
Progesterone—Nausea—Methotrexate—psoriasis	7.78e-06	0.000109	CcSEcCtD
Progesterone—ESR1—Gene Expression—CARM1—psoriasis	7.69e-06	0.000317	CbGpPWpGaD
Progesterone—NR3C1—Adipogenesis—IL6—psoriasis	7.69e-06	0.000316	CbGpPWpGaD
Progesterone—ABCB1—Allograft Rejection—TNF—psoriasis	7.62e-06	0.000314	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—NDUFA5—psoriasis	7.62e-06	0.000314	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	7.58e-06	0.000312	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—CARM1—psoriasis	7.58e-06	0.000312	CbGpPWpGaD
Progesterone—ESR1—Integrated Breast Cancer Pathway—TP53—psoriasis	7.56e-06	0.000311	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—CYP2S1—psoriasis	7.44e-06	0.000306	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	7.28e-06	0.0003	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—NDUFA5—psoriasis	7.18e-06	0.000296	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism—APOE—psoriasis	7.18e-06	0.000295	CbGpPWpGaD
Progesterone—ABCC1—Metabolism of lipids and lipoproteins—APOE—psoriasis	7.14e-06	0.000294	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—NDUFA5—psoriasis	7.12e-06	0.000293	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	7.11e-06	0.000293	CbGpPWpGaD
Progesterone—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	7.08e-06	0.000291	CbGpPWpGaD
Progesterone—OPRK1—GPCR ligand binding—CXCL8—psoriasis	6.99e-06	0.000288	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	6.9e-06	0.000284	CbGpPWpGaD
Progesterone—ESR1—Signaling by ERBB4—IL6—psoriasis	6.89e-06	0.000283	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—CAT—psoriasis	6.78e-06	0.000279	CbGpPWpGaD
Progesterone—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	6.76e-06	0.000278	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—CARM1—psoriasis	6.65e-06	0.000274	CbGpPWpGaD
Progesterone—ESR1—Generic Transcription Pathway—PPARG—psoriasis	6.65e-06	0.000274	CbGpPWpGaD
Progesterone—NR3C1—SIDS Susceptibility Pathways—IL6—psoriasis	6.64e-06	0.000273	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—CYP2S1—psoriasis	6.64e-06	0.000273	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	6.64e-06	0.000273	CbGpPWpGaD
Progesterone—NR3C1—Generic Transcription Pathway—PPARG—psoriasis	6.55e-06	0.00027	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—CYP2S1—psoriasis	6.48e-06	0.000267	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—CARM1—psoriasis	6.43e-06	0.000265	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	6.27e-06	0.000258	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism—PPARG—psoriasis	6.25e-06	0.000257	CbGpPWpGaD
Progesterone—ABCC1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	6.22e-06	0.000256	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—CYP2S1—psoriasis	6.11e-06	0.000251	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—NDUFA5—psoriasis	6.08e-06	0.00025	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—CYP2S1—psoriasis	6.05e-06	0.000249	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	6.01e-06	0.000247	CbGpPWpGaD
Progesterone—AR—Gene Expression—VDR—psoriasis	5.96e-06	0.000245	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CCL20—psoriasis	5.88e-06	0.000242	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—CARM1—psoriasis	5.8e-06	0.000239	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—CARM1—psoriasis	5.79e-06	0.000238	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—CAT—psoriasis	5.68e-06	0.000234	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	5.67e-06	0.000233	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—SOCS1—psoriasis	5.52e-06	0.000227	CbGpPWpGaD
Progesterone—PGR—Gene Expression—PPARG—psoriasis	5.46e-06	0.000225	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—CAT—psoriasis	5.45e-06	0.000224	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—CARM1—psoriasis	5.4e-06	0.000222	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—CARM1—psoriasis	5.32e-06	0.000219	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—APOE—psoriasis	5.27e-06	0.000217	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—CYP2S1—psoriasis	5.17e-06	0.000213	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	5.02e-06	0.000207	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	4.84e-06	0.000199	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—NDUFA5—psoriasis	4.7e-06	0.000193	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—VDR—psoriasis	4.59e-06	0.000189	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—PPARG—psoriasis	4.59e-06	0.000189	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—VDR—psoriasis	4.52e-06	0.000186	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—APOE—psoriasis	4.41e-06	0.000182	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	4.39e-06	0.000181	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—SOCS1—psoriasis	4.32e-06	0.000178	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	4.25e-06	0.000175	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—APOE—psoriasis	4.23e-06	0.000174	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—CARM1—psoriasis	4.19e-06	0.000173	CbGpPWpGaD
Progesterone—AR—Gene Expression—PPARG—psoriasis	4.16e-06	0.000171	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—TYK2—psoriasis	4.12e-06	0.00017	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—CAT—psoriasis	4.09e-06	0.000168	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—APOE—psoriasis	4.07e-06	0.000168	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—LEP—psoriasis	4.07e-06	0.000168	CbGpPWpGaD
Progesterone—ABCC1—Disease—HLA-A—psoriasis	4.07e-06	0.000167	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CYP2S1—psoriasis	3.99e-06	0.000164	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—CARM1—psoriasis	3.96e-06	0.000163	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—CAT—psoriasis	3.96e-06	0.000163	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—CXCL8—psoriasis	3.95e-06	0.000163	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.9e-06	0.00016	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—PPARG—psoriasis	3.84e-06	0.000158	CbGpPWpGaD
Progesterone—ABCC1—Disease—APOE—psoriasis	3.8e-06	0.000156	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—NFKBIA—psoriasis	3.79e-06	0.000156	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	3.76e-06	0.000155	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.7e-06	0.000152	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—PPARG—psoriasis	3.69e-06	0.000152	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—CARM1—psoriasis	3.63e-06	0.000149	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—CXCL8—psoriasis	3.59e-06	0.000148	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—CAT—psoriasis	3.57e-06	0.000147	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—CAT—psoriasis	3.56e-06	0.000147	CbGpPWpGaD
Progesterone—ABCC1—Disease—NOS2—psoriasis	3.54e-06	0.000146	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.48e-06	0.000143	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.4e-06	0.00014	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—CAT—psoriasis	3.32e-06	0.000137	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	3.32e-06	0.000136	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—CAT—psoriasis	3.27e-06	0.000135	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—CARM1—psoriasis	3.24e-06	0.000133	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—SOCS1—psoriasis	3.24e-06	0.000133	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—PPARG—psoriasis	3.2e-06	0.000132	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—LEP—psoriasis	3.19e-06	0.000131	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—APOE—psoriasis	3.19e-06	0.000131	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—APOE—psoriasis	3.18e-06	0.000131	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.17e-06	0.000131	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—CARM1—psoriasis	3.16e-06	0.00013	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—PPARG—psoriasis	3.15e-06	0.00013	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—TYK2—psoriasis	3.11e-06	0.000128	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—APOE—psoriasis	3.07e-06	0.000127	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.03e-06	0.000125	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—CARM1—psoriasis	2.98e-06	0.000123	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—NFKBIA—psoriasis	2.97e-06	0.000122	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—CARM1—psoriasis	2.96e-06	0.000122	CbGpPWpGaD
Progesterone—ABCC1—Disease—TYK2—psoriasis	2.9e-06	0.000119	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—APOE—psoriasis	2.77e-06	0.000114	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—PPARG—psoriasis	2.77e-06	0.000114	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—APOE—psoriasis	2.77e-06	0.000114	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.76e-06	0.000114	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.71e-06	0.000112	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—CXCL8—psoriasis	2.71e-06	0.000111	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PPARG—psoriasis	2.68e-06	0.00011	CbGpPWpGaD
Progesterone—ABCC1—Disease—CD4—psoriasis	2.62e-06	0.000108	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—APOE—psoriasis	2.58e-06	0.000106	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—CAT—psoriasis	2.58e-06	0.000106	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—APOE—psoriasis	2.54e-06	0.000105	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—CARM1—psoriasis	2.53e-06	0.000104	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—JUN—psoriasis	2.52e-06	0.000104	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—CAT—psoriasis	2.44e-06	0.0001	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—TYK2—psoriasis	2.43e-06	0.0001	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—NFKB1—psoriasis	2.42e-06	9.97e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PPARG—psoriasis	2.41e-06	9.94e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PPARG—psoriasis	2.41e-06	9.92e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—LEP—psoriasis	2.39e-06	9.84e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—APOE—psoriasis	2.39e-06	9.84e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.36e-06	9.72e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PPARG—psoriasis	2.25e-06	9.25e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—CAT—psoriasis	2.23e-06	9.19e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—NFKBIA—psoriasis	2.23e-06	9.17e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PPARG—psoriasis	2.21e-06	9.11e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—VEGFA—psoriasis	2.2e-06	9.05e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—STAT3—psoriasis	2.18e-06	8.96e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CXCL8—psoriasis	2.12e-06	8.72e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—STAT3—psoriasis	2.03e-06	8.35e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—IL6—psoriasis	2.02e-06	8.29e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—APOE—psoriasis	2e-06	8.25e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—CAT—psoriasis	1.99e-06	8.21e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—JUN—psoriasis	1.97e-06	8.11e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CARM1—psoriasis	1.95e-06	8.02e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—CAT—psoriasis	1.95e-06	8.01e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—NFKB1—psoriasis	1.9e-06	7.81e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—APOE—psoriasis	1.89e-06	7.79e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—CAT—psoriasis	1.83e-06	7.55e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—TYK2—psoriasis	1.82e-06	7.51e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—CAT—psoriasis	1.82e-06	7.48e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PPARG—psoriasis	1.75e-06	7.18e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—APOE—psoriasis	1.74e-06	7.14e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—VEGFA—psoriasis	1.72e-06	7.08e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—STAT3—psoriasis	1.7e-06	7.01e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—TP53—psoriasis	1.66e-06	6.83e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PPARG—psoriasis	1.65e-06	6.79e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CXCL8—psoriasis	1.59e-06	6.54e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—CAT—psoriasis	1.55e-06	6.39e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—APOE—psoriasis	1.55e-06	6.38e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—IL6—psoriasis	1.52e-06	6.26e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—APOE—psoriasis	1.51e-06	6.22e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PPARG—psoriasis	1.51e-06	6.22e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—JUN—psoriasis	1.48e-06	6.08e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—APOE—psoriasis	1.43e-06	5.87e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—NFKB1—psoriasis	1.42e-06	5.85e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—IL6—psoriasis	1.42e-06	5.83e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—APOE—psoriasis	1.41e-06	5.81e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PPARG—psoriasis	1.35e-06	5.55e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PPARG—psoriasis	1.32e-06	5.42e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—TP53—psoriasis	1.3e-06	5.35e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—VEGFA—psoriasis	1.29e-06	5.31e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—STAT3—psoriasis	1.28e-06	5.26e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PPARG—psoriasis	1.24e-06	5.11e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PPARG—psoriasis	1.23e-06	5.06e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—APOE—psoriasis	1.21e-06	4.97e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CAT—psoriasis	1.2e-06	4.94e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—IL6—psoriasis	1.19e-06	4.9e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PPARG—psoriasis	1.05e-06	4.33e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—TP53—psoriasis	9.75e-07	4.01e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—APOE—psoriasis	9.32e-07	3.83e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—IL6—psoriasis	8.92e-07	3.67e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PPARG—psoriasis	8.12e-07	3.34e-05	CbGpPWpGaD
